P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845112.68080.6b |
| _version_ | 1827332485465243648 |
|---|---|
| author | A. Schuh S. de Botton C. Recher S. Vives Polo E. Zarzycka J. Wang G. Bertani M. Heuser R. Calado S.-P. Yeh J. Hui S. Pandya D. Gianolio C. Chamberlain H. Dohner P. Montesinos |
| author_facet | A. Schuh S. de Botton C. Recher S. Vives Polo E. Zarzycka J. Wang G. Bertani M. Heuser R. Calado S.-P. Yeh J. Hui S. Pandya D. Gianolio C. Chamberlain H. Dohner P. Montesinos |
| author_sort | A. Schuh |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:39Z |
| format | Article |
| id | doaj.art-1d19f77e4e27470cb46d77eef9808da0 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:39Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-1d19f77e4e27470cb46d77eef9808da02024-03-03T03:19:39ZengWileyHemaSphere2572-92412022-06-01645545610.1097/01.HS9.0000845112.68080.6b202206003-00455P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINEA. Schuh0S. de Botton1C. Recher2S. Vives Polo3E. Zarzycka4J. Wang5G. Bertani6M. Heuser7R. Calado8S.-P. Yeh9J. Hui10S. Pandya11D. Gianolio12C. Chamberlain13H. Dohner14P. Montesinos151 Princess Margaret Cancer Centre, Toronto, Canada2 Institut Gustave Roussy, Villejuif3 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France4 Hospital Universitario Germans Trias i Pujol-ICO Badalona, Josep Carreras Research Institute, Badalona, Spain5 Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland6 Institute of Hematology & Hospital of Blood Disease, Tianjin, China7 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy8 Hannover Medical School, Hannover, Germany9 Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil10 China Medical University, Taichung, Taiwan11 Servier Pharmaceuticals LLC, Boston, United States of America11 Servier Pharmaceuticals LLC, Boston, United States of America11 Servier Pharmaceuticals LLC, Boston, United States of America11 Servier Pharmaceuticals LLC, Boston, United States of America12 Ulm University Hospital, Ulm, Germany13 Hospital Universitari i Politècnic La Fe, València, Spainhttp://journals.lww.com/10.1097/01.HS9.0000845112.68080.6b |
| spellingShingle | A. Schuh S. de Botton C. Recher S. Vives Polo E. Zarzycka J. Wang G. Bertani M. Heuser R. Calado S.-P. Yeh J. Hui S. Pandya D. Gianolio C. Chamberlain H. Dohner P. Montesinos P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE HemaSphere |
| title | P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE |
| title_full | P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE |
| title_fullStr | P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE |
| title_full_unstemmed | P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE |
| title_short | P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE |
| title_sort | p556 changes in health related quality of life in patients with newly diagnosed acute myeloid leukemia receiving ivosidenib azacitidine or placebo azacitidine |
| url | http://journals.lww.com/10.1097/01.HS9.0000845112.68080.6b |
| work_keys_str_mv | AT aschuh p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT sdebotton p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT crecher p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT svivespolo p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT ezarzycka p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT jwang p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT gbertani p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT mheuser p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT rcalado p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT spyeh p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT jhui p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT spandya p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT dgianolio p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT cchamberlain p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT hdohner p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine AT pmontesinos p556changesinhealthrelatedqualityoflifeinpatientswithnewlydiagnosedacutemyeloidleukemiareceivingivosidenibazacitidineorplaceboazacitidine |